Evidence map›Paper›PMID 35392129›Full record

ArticleToxicon: X2022

Does probiotic Kefir reduce dyslipidemia, hematological disorders and oxidative stress induced by zearalenone toxicity in wistar rats?

Fadia Ben Taheur, Chalbia Mansour, Sondes Mechri, Sihem Safta Skhiri, Bassem Jaouadi, Ridha Mzoughi, Kamel Chaieb, Nacim Zouari

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxicon: X, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Fadia Ben TaheurLaboratory of Analysis, Treatment and Valorization of Environmental Pollutants and Products, Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.
Chalbia MansourLaboratory of Analysis, Treatment and Valorization of Environmental Pollutants and Products, Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.
Sondes MechriLaboratory of Microbial Biotechnology, Enzymatic, and Biomolecules (LMBEB), Centre of Biotechnology of Sfax (CBS), University of Sfax, Sfax, Tunisia.
Sihem Safta SkhiriABCDF Laboratory, Faculty of Dental Medicine, University of Monastir, Monastir, Tunisia.
Bassem JaouadiLaboratory of Microbial Biotechnology, Enzymatic, and Biomolecules (LMBEB), Centre of Biotechnology of Sfax (CBS), University of Sfax, Sfax, Tunisia.
Ridha MzoughiLaboratory of Analysis, Treatment and Valorization of Environmental Pollutants and Products, Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.
Kamel ChaiebLaboratory of Analysis, Treatment and Valorization of Environmental Pollutants and Products, Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.
Nacim ZouariHigher Institute of Applied Biology of Medenine (ISBAM), University of Gabes, Medenine, Tunisia.
University of Monastir · TNUniversity of Sfax · TNUniversity of Gabès · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zearalenone (ZEA) is a toxic metabolite of the genus

Indexed as

Antioxidant potentialHepatotoxicityKefirRatZearalenone (ZEA)

Identifiers

PMID35392129
PMCPMC8980486
OpenAlexW4221014702

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.